✦ LIBER ✦

Treatment with interferon beta-1b delays conversion to clinically definite and McDonald MS in patients with clinically isolated syndromes

✍ Scribed by Kappos, L.; Polman, C. H.; Freedman, M. S.; Edan, G.; Hartung, H. P.; Miller, D. H.; Montalban, X.; Barkhof, F.; Bauer, L.; Jakobs, P.; Pohl, C.; Sandbrink, R.

Book ID: 125450221
Publisher: Lippincott Williams and Wilkins
Year: 2006
Tongue: English
Weight: 465 KB
Volume: 67
Category: Article
ISSN: 0028-3878
DOI: 10.1212/01.wnl.0000237641.33768.8d

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Treatment with interferon beta-1b delays

Treatment with interferon beta-1b delays conversion to clinically definite and McDonald MS in patients with clinically isolated syndromes

✍ L. Kappos; C.H. Polman; M.S. Freedman; G. Edan; H.P. Hartung; D.H. Miller; X. Mo 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 49 KB

PND15 COST-UTILITY OF INTERFERON BETA-1B

PND15 COST-UTILITY OF INTERFERON BETA-1B IN THE TREATMENT OF PATIENTS WITH A CLINICALLY ISOLATED SYNDROME SUGGESTIVE OF MULTIPLE SCLEROSIS

✍ JP Caloyeras; C Wang; L Bauer; WC Lee; V Lanius; K Gondek 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 67 KB

Good results for early treatment of clin

Good results for early treatment of clinically isolated syndrome prior to multiple sclerosis with interferon beta-1b and glatiramer group

✍ Doggrell, Sheila A 📂 Article 📅 2010 🏛 Informa plc 🌐 English ⚖ 207 KB

PND26 COST-UTILITY OF INTERFERON BETA-1B

PND26 COST-UTILITY OF INTERFERON BETA-1B IN THE TREATMENT OF PATIENTS WITH A CLINICALLY ISOLATED SYNDROME SUGGESTIVE OF MULTIPLE SCLEROSIS IN SPAIN

✍ T Arbizu; C Piñol; V Casado 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 80 KB

The effect of interferon-beta1a on relap

The effect of interferon-beta1a on relapses and progression of disability in patients with clinically isolated syndromes (CIS) suggestive of multiple sclerosis

✍ Mohammad Reza Motamed; Neda Najimi; Seyed-Mohammad Fereshtehnejad 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 210 KB

ND4 COST-UTILITY OF INTERFERON BETA-1B I

ND4 COST-UTILITY OF INTERFERON BETA-1B IN THE TREATMENT OF PATIENTS WITH A CLINICALLY ISOLATED SYNDROME SUGGESTIVE OF MULTIPLE SCLEROSIS: MODEL UTILIZING FIVE YEAR BENEFIT DATA

✍ JP Caloyeras; B Harrow; C Wang; K Beckmann; V Knappertz; C Pohl; JD Miller; MW R 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 88 KB